Aidikoff, Uhl & Bakhtiari (www.securitiesarbitration.com) announces the filing of additional FINRA arbitration claims against brokerage firms that sold Medical Capital and other securities to investors.
To date the firm has filed claims on behalf of more than 25 families seeking more than $10 million in damages against several brokerage firms. The individual brokers and individual advisors who sold Medical Capital are not targets of investor claims.
“Investors should be aware of a pending class action, said attorney David S. Harrison. “The class case may have certain pitfalls that investors should be aware of in selecting an attorney. Most individual investors will fare better by pursuing an individual FINRA arbitration.”
Medical Capital Corporation and Medical Provider Funding Corporation VI raised more than $2.2 billion through the offering of notes in Medical Provider Funding Corp VI and earlier special purpose entity offerings.
“Often the most important choice an investor makes following a disaster like Medical Capital is the remedy they will pursue to vindicate their rights,” said attorney Ryan K. Bakhtiari. “Investors should carefully consider their options.”
Important Facts to Consider Prior to Joining a Medical Capital Class Action
- Many investors may have viable claims based on the investments’ unsuitability. Because a suitability claim is dependent on an individual’s circumstances, this claim cannot be prosecuted on a class wide basis.
- Investors with significant losses are likely to recover only pennies on the dollar through a class action.
- Class actions sometimes create hurdles to recovery for individual investors including depositions and motion practice which are generally not permitted in securities arbitrations decided before FINRA. The FINRA arbitration process can usually be completed in a much shorter period of time, often 15 months. Recovery through a class action may take several years.
No comments:
Post a Comment